ARISTO BIO-TECH AN
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of ARISTO BIO-TECH AN generated cash of $76,004,000, which is more than the previous year. Cash used in financing activities reached the amount of -$22,066,000 last year. Net change in cash is therefore -$12,158,000.
Cash Flow
| 2020 | 14.07M | -21.92M | 8.72M |
|---|---|---|---|
| 2023 | -27.83M | -37.45M | 79.65M |
| 2024 | 76.00M | -66.09M | -22.06M |
ARISTO-SM.NS Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2019 | |
|---|---|---|---|
Cash at beginning of period | 18.52M | 4.16M | 4.37M |
Operating activities | |||
Net income | 38.95M | 35.62M | 10.07M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 15.70M | 15.36M | 5.19M |
Stock-based compensation expense | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | -128.99M | -113.72M | -60.41M |
Inventories | -94.09M | -64.15M | 86.63M |
Accounts payable | 0 | 0 | 0 |
Cash generated by operating activities | 76.00M | -27.83M | 14.07M |
Investing activities | |||
Purchases Of Investments | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -65.54M | -40.60M | -22.00M |
Acquisitions Net | 0 | 0 | 0 |
Cash generated by investing activities | -66.09M | -37.45M | -21.92M |
Financing activities | |||
Common Stock Issued | 0 | 0 | 0 |
Payments for dividends | -4.42M | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | -1.69M | -9.25M | 34.73M |
Cash used in financing activities | -22.06M | 79.65M | 8.72M |
Net Change In Cash | -12.15M | 14.36M | 872K |
Cash at end of period | 6.37M | 18.52M | 5.25M |
| Data source | Data source | Data source |